A bipartisan group of legislators have introduced a bill at the roundhouse that would allow New Mexicans to take psychedelic ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

The Cambridge, Mass., biotechnology company on Thursday said it received a notice of allowance from the U.S. Patent and Trademark Office regarding the drug candidate, ED-003, which is intended to ...

If approved, the 2025 proposals would allow for a two-year development phase before the state starts handing out licenses in ...

The potential legalization of magic mushrooms is heading to Olympia next week as state lawmakers prepare to hear testimony on ...

Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to ...

Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

The one-two punch sent newly consolidated shares tumbling despite progress on its non-hallucinogenic depression treatment.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

Legislation to create a program for the medicinal use of psilocybin was introduced today in the New Mexico Senate. Senate Bill 219, the Medical Psilocybin Act, would allow those in New Mexico to ...

A group of lawmakers introduced a proposal Thursday to establish a program for medicinal use of psilocybin mushrooms.